Search Results - Egendal, Ida

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Gene Expressions and High Lymphocyte Count May Predict Durable Clinical Benefits in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors

    Gene Expressions and High Lymphocyte Count May Predict Durable Clinical Benefits in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors by Mouritzen, Mette T, Ladekarl, Morten, Hager, Henrik, Mattesen, Trine B, Lippert, Julie B, Frank, Malene S, Nøhr, Anne K, Egendal, Ida B, Carus, Andreas

    Published in Cancers
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01)

    A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01) by Rasmussen, Louise Skau, Winther, Stine B, Chen, Inna M, Weber, Britta, Ventzel, Lise, Liposits, Gabor, Johansen, Julia Sidenius, Detlefsen, Sönke, Egendal, Ida, Shim, Susy, Christensen, Signe, Pfeiffer, Per, Ladekarl, Morten

    Published in BMC cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: